ImpediMed Limited (ASX:IPD)
Australia flag Australia · Delayed Price · Currency is AUD
0.0160
0.00 (0.00%)
Mar 18, 2026, 4:10 PM AEST

ImpediMed Cash Flow Statement

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Net Income
-24.37-23.24-19.79-20.52-19.87-20.71
Depreciation & Amortization
0.470.570.580.551.240.35
Other Amortization
3.993.991.671.921.811.3
Asset Writedown & Restructuring Costs
-----0.05
Stock-Based Compensation
1.61.6-0.680.7533.04
Provision & Write-off of Bad Debts
0.050.05-0.23-0.65-0.45-0.3
Other Operating Activities
0.980.49-0.020.330.40.64
Change in Accounts Receivable
1.081.081.180.180.04-0.08
Change in Inventory
-0.1-0.10.050.12-0.550.49
Change in Accounts Payable
-0.06-0.060.12-0.891.53-0.28
Change in Other Net Operating Assets
0.970.97-0.670.17-2.792.26
Operating Cash Flow
-15.39-14.65-17.79-18.05-15.66-13.26
Capital Expenditures
-0.06-0.06-0.08-0.39-0.06-0.07
Sale (Purchase) of Intangibles
-0.81-0.93-3.02-5.65-5.16-2.39
Other Investing Activities
-0.03-----
Investing Cash Flow
-0.91-0.99-3.11-6.04-5.22-2.46
Long-Term Debt Issued
-15.97---0.17
Long-Term Debt Repaid
--0.42-0.48-0.43-0.37-0.41
Net Debt Issued (Repaid)
23.2715.55-0.48-0.43-0.37-0.24
Issuance of Common Stock
--0.0630.0242.516.84
Other Financing Activities
-3.35-1.9-0.06-1.67-2.21-0.13
Financing Cash Flow
19.9213.64-0.4827.9339.9216.47
Foreign Exchange Rate Adjustments
-2.47-0.460.31.142.02-0.73
Net Cash Flow
1.15-2.45-21.084.9821.050.02
Free Cash Flow
-15.45-14.71-17.87-18.44-15.72-13.32
Free Cash Flow Margin
-108.54%-115.57%-173.18%-162.56%-148.82%-158.45%
Free Cash Flow Per Share
-0.01-0.01-0.01-0.01-0.01-0.01
Cash Interest Paid
2.030.58----
Levered Free Cash Flow
-10.88-9.36-15.83-18.95-13.31-9.13
Unlevered Free Cash Flow
-8.98-8.63-15.77-18.93-13.3-9.1
Change in Working Capital
1.891.890.68-0.43-1.782.38
Source: S&P Global Market Intelligence. Standard template. Financial Sources.